|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 5/00 | |
| C07K 1/00 | |||
| C07K 14/00 |
| (11) | Number of the document | 2070944 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09004305.0 |
| Date of filing the European patent application | 2002-10-11 | |
| (97) | Date of publication of the European application | 2009-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2012-09-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 328624 P | 2001-10-11 | US | |
| 414155 P | 2002-09-27 | US | |
| 269695 | 2002-10-10 | US |
| (72) |
Oliner, Jonathan, Daniel, US
Min, Hosung, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | Specific binding agents of human angiopoietin-2 |
| Specific binding agents of human angiopoietin-2 |